Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Coronavirus Report – Part 48: Stagnation of Chinese Pharmaceutical Intermediates Causes Market Disruption

Filed Under: Coronavirus, Industry Tagged With: , , , ,

Pharmaceutical intermediate supplies out of China – a major hub for production – have stagnated. On top of the spread…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

India Moves to Shed Dependence on China for Active Pharmaceutical Ingredients
India Moves to Shed Dependence on China for Active…
Coronavirus Expected to Shortchange Japan’s Pharmaceutical Market by up to 300B Yen
Coronavirus Expected to Shortchange Japan’s Pharmaceutical…
Coronavirus Report – Part 89: Japanese Materials and Chemicals Companies See Rush of Contract Production Activity
Coronavirus Report – Part 89: Japanese Materials and…
Coronavirus Report – Part 77: Japan’s Pharmaceutical Companies Move in Quick Order to Treat Infection
Coronavirus Report – Part 77: Japan’s Pharmaceutical…
Coronavirus Report – Part 84: Acetone Value in Asia Skyrockets as COVID-19 Pushes Derivative Demand
Coronavirus Report – Part 84: Acetone Value in Asia…
Major Chemical and Raw Material Companies Post Higher Than Expected Results From Health Care Operations
Major Chemical and Raw Material Companies Post Higher Than…